CA 15-3 Levels and Survival in Metastatic Breast Cancer
Author Information
Author(s): M Tampellini, A Berruti, A Gerbino, T Buniva, M Torta, G Gorzegno, R Faggiuolo, R Cannone, A Farris, M Destefanis, G Moro, F Deltetto, L Dogliotti
Primary Institution: Universita di Torino, Azienda Ospedaliera San Luigi
Hypothesis
The study aims to evaluate the relationship between serum CA 15-3 levels and the tumor load at first relapse of disease in predicting survival of metastatic breast cancer patients.
Conclusion
CA 15-3 is not an independent variable in determining survival; its prognostic role is linked to the disease extent.
Supporting Evidence
- Higher CA 15-3 serum levels were found in patients with visceral metastases or pleural effusion.
- Univariate survival analysis confirmed the positive prognostic influence of low CA 15-3 serum levels.
- Multivariate analysis showed that disease extent was a significant prognostic factor.
Takeaway
This study looked at a blood test called CA 15-3 to see if it can help doctors understand how serious breast cancer is and how long patients might live.
Methodology
The study followed 312 breast cancer patients from October 1988 to March 1995, assessing CA 15-3 levels and disease extent to predict survival.
Limitations
About 25% of patients had non-measurable disease, which limited the assessment of tumor load.
Participant Demographics
Median age was 57 years, with 27% premenopausal and 72% menopausal patients.
Statistical Information
P-Value
< 0.001
Statistical Significance
p<0.001
Want to read the original?
Access the complete publication on the publisher's website